{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T10:31:21Z","timestamp":1794479481832,"version":"4.9.1"},"reference-count":219,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2024NSFSC1907"],"award-info":[{"award-number":["2024NSFSC1907"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","award":["024HXBHI31"],"award-info":[{"award-number":["024HXBHI31"]}],"id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013365","name":"West China Hospital, Sichuan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203029"],"award-info":[{"award-number":["82203029"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.biopha.2026.119472","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T18:06:34Z","timestamp":1778090794000},"page":"119472","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Advances in mechanisms and treatments of brain metastases"],"prefix":"10.1016","volume":"199","author":[{"given":"Weijian","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manni","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119472_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41572-018-0055-y","article-title":"Brain metastases","volume":"5","author":"Achrol","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.biopha.2026.119472_bib2","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1093\/neuonc\/noab101","article-title":"Epidemiology of brain metastases and leptomeningeal disease","volume":"23","author":"Lamba","year":"2021","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.biopha.2026.119472_bib3","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1200\/JCO.20.01255","article-title":"Survival in patients with brain metastases: summary report on the updated diagnosis-specific graded prognostic assessment and definition of the eligibility quotient","volume":"38","author":"Sperduto","year":"2020","journal-title":"JCO"},{"key":"10.1016\/j.biopha.2026.119472_bib4","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s13402-017-0345-5","article-title":"Lung cancer-associated brain metastasis: Molecular mechanisms and therapeutic options","volume":"40","author":"Yousefi","year":"2017","journal-title":"Cell Oncol."},{"key":"10.1016\/j.biopha.2026.119472_bib5","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s10585-024-10309-y","article-title":"PD-L1 and VEGF dual blockade enhances anti-tumor effect on brain metastasis in hematogenous metastasis model","volume":"41","author":"Masuda","year":"2024","journal-title":"Clin. Exp. Metastas"},{"key":"10.1016\/j.biopha.2026.119472_bib6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41568-019-0205-x","article-title":"The blood\u2013brain barrier and blood\u2013tumour barrier in brain tumours and metastases","volume":"20","author":"Arvanitis","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2026.119472_bib7","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1158\/0008-5472.CAN-22-3964","article-title":"Active Remodeling of Capillary Endothelium via Cancer Cell\u2013Derived MMP9 Promotes Metastatic Brain Colonization","volume":"83","author":"Karreman","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2026.119472_bib8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s40478-025-01985-2","article-title":"Unveiling the intricate dynamics of the interplay between triple-negative breast cancer cells and the blood-brain barrier endothelium","volume":"13","author":"Garcia","year":"2025","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.biopha.2026.119472_bib9","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nm.2072","article-title":"Real-time imaging reveals the single steps of brain metastasis formation","volume":"16","author":"Kienast","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2026.119472_bib10","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1016\/j.neuron.2024.07.026","article-title":"Single-cell dissection of the human blood-brain barrier and glioma blood-tumor barrier","volume":"112","author":"Xie","year":"2024","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2026.119472_bib11","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nature13989","article-title":"Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors","volume":"518","author":"Gomez Perdiguero","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119472_bib12","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1016\/j.celrep.2016.10.052","article-title":"Macrophage ontogeny underlies differences in tumor-specific education in brain malignancies","volume":"17","author":"Bowman","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2026.119472_bib13","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.1158\/0008-5472.CAN-18-0118","article-title":"Combined Blockade of IL6 and PD-1\/PD-L1 signaling abrogates mutual regulation of their immunosuppressive effects in the tumor microenvironment","volume":"78","author":"Tsukamoto","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2026.119472_bib14","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.cell.2020.05.007","article-title":"Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune Cells","volume":"181","author":"Klemm","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2026.119472_bib15","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1080\/00207454.2018.1545771","article-title":"Neurogenesis in the adult hippocampus: history, regulation, and prospective roles","volume":"129","author":"Fares","year":"2019","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.biopha.2026.119472_bib16","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1038\/onc.2012.417","article-title":"Neurotrophin-3 modulates breast cancer cells and the microenvironment to promote the growth of breast cancer brain metastasis","volume":"32","author":"Louie","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2026.119472_bib17","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.imbio.2013.06.003","article-title":"Tumor associated macrophages and neutrophils in cancer","volume":"218","author":"Galdiero","year":"2013","journal-title":"Immunobiology"},{"key":"10.1016\/j.biopha.2026.119472_bib18","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1038\/s41556-024-01509-5","article-title":"Astrocyte-induced Cdk5 expedites breast cancer brain metastasis by suppressing MHC-I expression to evade immune recognition","volume":"26","author":"Yuzhalin","year":"2024","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.biopha.2026.119472_bib19","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41388-019-0959-3","article-title":"TGLI1 transcription factor mediates breast cancer brain metastasis via activating metastasis-initiating cancer stem cells and astrocytes in the tumor microenvironment","volume":"39","author":"Sirkisoon","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2026.119472_bib20","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/s41556-023-01241-6","article-title":"Crosstalk between small-cell lung cancer cells and astrocytes mimics brain development to promote brain metastasis","volume":"25","author":"Qu","year":"2023","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.biopha.2026.119472_bib21","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/s41591-018-0044-4","article-title":"STAT3 labels a subpopulation of reactive astrocytes required for brain metastasis","volume":"24","author":"Priego","year":"2018","journal-title":"Nat. Med"},{"key":"10.1016\/j.biopha.2026.119472_bib22","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1093\/neuonc\/noaf187","article-title":"STAT3 expression in brain metastases from breast cancer is correlated with molecular subtype and impacts clinical outcome","volume":"27","author":"Pellerino","year":"2025","journal-title":"Neuro-Oncol."},{"key":"10.1016\/j.biopha.2026.119472_bib23","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.bbrc.2018.03.053","article-title":"Programmed death ligand 1 expression and CD8+ tumor-infiltrating lymphocyte density differences between paired primary and brain metastatic lesions in non-small cell lung cancer","volume":"498","author":"Zhou","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2026.119472_bib24","doi-asserted-by":"crossref","unstructured":"Jansen C.S., Prabhu R.S., Pagadala M.S., Chappa P., Goyal S., Zhou C., et al. Immune niches in brain metastases contain TCF1+ stem-like T cells, are associated with disease control and are modulated by preoperative SRS 2023. \u3008https:\/\/doi.org\/10.21203\/rs.3.rs-2722744\/v1\u3009.","DOI":"10.21203\/rs.3.rs-2722744\/v1"},{"key":"10.1016\/j.biopha.2026.119472_bib25","unstructured":"A.S. Berghoff, V.A. Venur, M. Preusser, M.S. Ahluwalia, 2025, Immune Checkpoint Inhibitors in Brain Metastases: From Biology to Treatment 2025."},{"key":"10.1016\/j.biopha.2026.119472_bib26","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.lungcan.2011.06.002","article-title":"Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cells","volume":"75","author":"Tao","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.biopha.2026.119472_bib27","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/vaccines4030028","article-title":"Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting","volume":"4","author":"Chaudhary","year":"2016","journal-title":"Vaccines"},{"key":"10.1016\/j.biopha.2026.119472_bib28","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/s41590-019-0578-8","article-title":"Genome-wide CRISPR\u2013Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1","volume":"21","author":"Crowther","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biopha.2026.119472_bib29","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.cell.2018.01.004","article-title":"NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control","volume":"172","author":"B\u00f6ttcher","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2026.119472_bib30","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1093\/brain\/awab012","article-title":"Emerging principles of brain immunology and immune checkpoint blockade in brain metastases","volume":"144","author":"Fares","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.biopha.2026.119472_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202203699","article-title":"The Single-Cell Landscape of Intratumoral Heterogeneity and The Immunosuppressive Microenvironment in Liver and Brain Metastases of Breast Cancer","volume":"10","author":"Zou","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biopha.2026.119472_bib32","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12964-019-0362-2","article-title":"Cancer-associated fibroblasts in radiotherapy: challenges and new opportunities","volume":"17","author":"Wang","year":"2019","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.biopha.2026.119472_bib33","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41568-020-00320-2","article-title":"The metabolism of cancer cells during metastasis","volume":"21","author":"Bergers","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2026.119472_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.791927","article-title":"Metabolic reprogramming underlying brain metastasis of breast cancer","volume":"8","author":"Liu","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.biopha.2026.119472_bib35","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1158\/0008-5472.CAN-17-0764","article-title":"Monocarboxylate Transporter MCT1 Promotes Tumor Metastasis Independently of Its Activity as a Lactate Transporter","volume":"77","author":"Payen","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2026.119472_bib36","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1111\/jcmm.14276","article-title":"Targeting the ROS\/PI3K\/AKT\/HIF-1\u03b1\/HK2 axis of breast cancer cells: Combined administration of Polydatin and 2-Deoxy-d-glucose","volume":"23","author":"Zhang","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.biopha.2026.119472_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.550469","article-title":"PKM2\u2013c-Myc\u2013Survivin Cascade Regulates the Cell Proliferation, Migration, and Tamoxifen Resistance in Breast Cancer","volume":"11","author":"Yu","year":"2020","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2026.119472_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-022-04632-z","article-title":"Zeb1-induced metabolic reprogramming of glycolysis is essential for macrophage polarization in breast cancer","volume":"13","author":"Jiang","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2026.119472_bib39","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-025-03315-9","article-title":"GABA regulates metabolic reprogramming to mediate the development of brain metastasis in non-small cell lung cancer","volume":"44","author":"Xie","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2026.119472_bib40","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nature20791","article-title":"Targeting metastasis-initiating cells through the fatty acid receptor CD36","volume":"541","author":"Pascual","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119472_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2018.00159","article-title":"Potential Molecular Signatures Predictive of Lung Cancer Brain Metastasis","volume":"8","author":"Pedrosa","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2026.119472_bib42","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41568-019-0220-y","article-title":"Brain metastasis","volume":"20","author":"Boire","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2026.119472_bib43","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1177\/0192623319838491","article-title":"Epithelial\u2013mesenchymal Transition Phenotypes in Vertebral Metastases of Lung Cancer","volume":"47","author":"Dieterly","year":"2019","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.biopha.2026.119472_bib44","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.ccell.2023.07.012","article-title":"CD44+ lung cancer stem cell-derived pericyte-like cells cause brain metastases through GPR124-enhanced trans-endothelial migration","volume":"41","author":"Huang","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biopha.2026.119472_bib45","doi-asserted-by":"crossref","first-page":"4999","DOI":"10.18632\/aging.202324","article-title":"HOXB9 enhances the ability of lung cancer cells to penetrate the blood-brain barrier","volume":"13","author":"Zheng","year":"2021","journal-title":"Aging"},{"key":"10.1016\/j.biopha.2026.119472_bib46","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/s41419-021-04004-z","article-title":"TGF-\u03b21-mediated exosomal lnc-MMP2-2 increases blood\u2013brain barrier permeability via the miRNA-1207-5p\/EPB41L5 axis to promote non-small cell lung cancer brain metastasis","volume":"12","author":"Wu","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2026.119472_bib47","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/neuonc\/noaa028","article-title":"ALCAM contributes to brain metastasis formation in non-small-cell lung cancer through interaction with the vascular endothelium","volume":"22","author":"M\u00fcnsterberg","year":"2020","journal-title":"Neuro-Oncol."},{"key":"10.1016\/j.biopha.2026.119472_bib48","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1158\/0008-5472.CAN-21-4160","article-title":"Developmental Pathways Are Epigenetically Reprogrammed during Lung Cancer Brain Metastasis","volume":"82","author":"Karlow","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2026.119472_bib49","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s12094-015-1347-2","article-title":"miRNA-197 and miRNA-184 are associated with brain metastasis in EGFR-mutant lung cancers","volume":"18","author":"Remon","year":"2016","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.biopha.2026.119472_bib50","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/s41419-022-05062-7","article-title":"miR-596-3p suppresses brain metastasis of non-small cell lung cancer by modulating YAP1 and IL-8","volume":"13","author":"Li","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2026.119472_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1297988","article-title":"Brain metastases and lung cancer: molecular biology, natural history, prediction of response and efficacy of immunotherapy","volume":"14","author":"Sereno","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2026.119472_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2022.166557","article-title":"Small-cell lung cancer brain metastasis: From molecular mechanisms to diagnosis and treatment","volume":"1868","author":"Zhu","year":"2022","journal-title":"Biochim. Et. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.biopha.2026.119472_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2023.119451","article-title":"CEMIP-mediated hyaluronan metabolism facilitates SCLC metastasis by activating TLR2\/c-Src\/ERK1\/2 axis","volume":"1870","author":"Li","year":"2023","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"},{"key":"10.1016\/j.biopha.2026.119472_bib54","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/annonc\/mdz122","article-title":"Prognostic value of circulating tumour cells in limited-stage small-cell lung cancer: analysis of the concurrent once-daily versus twice-daily radiotherapy (CONVERT) randomised controlled trial","volume":"30","author":"Tay","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.biopha.2026.119472_bib55","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00401-017-1757-z","article-title":"RNAi screen identifies essential regulators of human brain metastasis-initiating cells","volume":"134","author":"Singh","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.biopha.2026.119472_bib56","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.7150\/thno.33680","article-title":"CDYL promotes the chemoresistance of small cell lung cancer by regulating H3K27 trimethylation at the CDKN1C promoter","volume":"9","author":"Qiu","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2026.119472_bib57","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.biopha.2026.119472_bib58","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-020-1140-x","article-title":"microRNAs Orchestrate Pathophysiology of Breast Cancer Brain Metastasis: Advances in Therapy","volume":"19","author":"Kanchan","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2026.119472_bib59","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/s41416-021-01424-8","article-title":"Breast cancer brain metastasis: insight into molecular mechanisms and therapeutic strategies","volume":"125","author":"Wang","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2026.119472_bib60","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.bbcan.2017.03.004","article-title":"Brain metastasization of breast cancer","volume":"1868","author":"Cust\u00f3dio-Santos","year":"2017","journal-title":"Biochimica et Biophysica Acta (BBA) - Reviews Cancer"},{"key":"10.1016\/j.biopha.2026.119472_bib61","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/neuonc\/noy044","article-title":"Breast cancer brain metastasis: molecular mechanisms and directions for treatment","volume":"20","author":"Pedrosa","year":"2018","journal-title":"Neuro-Oncol."},{"key":"10.1016\/j.biopha.2026.119472_bib62","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.31557\/APJCP.2023.24.9.2997","article-title":"Upregulation of Matrix Metalloproteinases in the Metastatic Cascade of Breast Cancer to the Brain","volume":"24","author":"Kamalabadi Farahani","year":"2023","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.biopha.2026.119472_bib63","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/ijc.31090","article-title":"ADAM8 expression in breast cancer derived brain metastases: Functional implications on MMP-9 expression and transendothelial migration in breast cancer cells","volume":"142","author":"Conrad","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.biopha.2026.119472_bib64","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1158\/2159-8290.CD-19-0384","article-title":"Circulating Tumor Cells Exhibit Metastatic Tropism and Reveal Brain Metastasis Drivers","volume":"10","author":"Klotz","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.biopha.2026.119472_bib65","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.ccell.2020.10.004","article-title":"YTHDF3 Induces the Translation of m6A-Enriched Gene Transcripts to Promote Breast Cancer Brain Metastasis","volume":"38","author":"Chang","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biopha.2026.119472_bib66","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/neuonc\/noad175","article-title":"SRRM4-mediated REST to REST4 dysregulation promotes tumor growth and neural adaptation in breast cancer leading to brain metastasis","volume":"26","author":"Deshpande","year":"2024","journal-title":"Neuro-Oncol."},{"key":"10.1016\/j.biopha.2026.119472_bib67","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1038\/s41467-020-16832-2","article-title":"Rab11b-mediated integrin recycling promotes brain metastatic adaptation and outgrowth","volume":"11","author":"Howe","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119472_bib68","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax8933","article-title":"Connexins orchestrate progression of breast cancer metastasis to the brain by promoting FAK activation","volume":"14","author":"Lorusso","year":"2022","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.biopha.2026.119472_bib69","doi-asserted-by":"crossref","first-page":"6209","DOI":"10.1158\/1078-0432.CCR-21-0361","article-title":"IL13R\u03b12 Promotes Proliferation and Outgrowth of Breast Cancer Brain Metastases","volume":"27","author":"M\u00e1rquez-Ortiz","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2026.119472_bib70","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.7150\/ijbs.58916","article-title":"Circular RNA circBCBM1 promotes breast cancer brain metastasis by modulating miR-125a\/BRD4 axis","volume":"17","author":"Fu","year":"2021","journal-title":"Int J. Biol. Sci."},{"key":"10.1016\/j.biopha.2026.119472_bib71","doi-asserted-by":"crossref","first-page":"6445","DOI":"10.1038\/s41388-019-0893-4","article-title":"FABP7 is a key metabolic regulator in HER2+ breast cancer brain metastasis","volume":"38","author":"Cordero","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2026.119472_bib72","first-page":"42","article-title":"RARRES2\u2019s impact on lipid metabolism in triple-negative breast cancer: a pathway to brain metastasis","volume":"10","author":"Shubhra","year":"2023","journal-title":"Mil. Med Res"},{"key":"10.1016\/j.biopha.2026.119472_bib73","article-title":"RARRES2 regulates lipid metabolic reprogramming to mediate the development of brain metastasis in triple negative breast cancer","volume":"10","author":"Li","year":"2023","journal-title":"Mil. Med Res"},{"key":"10.1016\/j.biopha.2026.119472_bib74","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/14728222.2022.2077189","article-title":"Fatty acid synthase: a druggable driver of breast cancer brain metastasis","volume":"26","author":"Menendez","year":"2022","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.biopha.2026.119472_bib75","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/neuonc\/noz198","article-title":"GRP94 promotes brain metastasis by engaging pro-survival autophagy","volume":"22","author":"Santana-Codina","year":"2020","journal-title":"Neuro-Oncol."},{"key":"10.1016\/j.biopha.2026.119472_bib76","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/s43018-023-00563-6","article-title":"Limiting mitochondrial plasticity by targeting DRP1 induces metabolic reprogramming and reduces breast cancer brain metastases","volume":"4","author":"Parida","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.biopha.2026.119472_bib77","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/s41556-024-01446-3","article-title":"Loss of Kmt2c or Kmt2d drives brain metastasis via KDM6A-dependent upregulation of MMP3","volume":"26","author":"Seehawer","year":"2024","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.biopha.2026.119472_bib78","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.ccell.2024.08.015","article-title":"Distinct tumor architectures and microenvironments for the initiation of breast cancer metastasis in the brain","volume":"42","author":"Gan","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biopha.2026.119472_bib79","article-title":"Epidemiology of synchronous brain metastases","volume":"2","author":"Singh","year":"2020","journal-title":"Neuro-Oncol. Adv."},{"key":"10.1016\/j.biopha.2026.119472_bib80","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-018-0854-5","article-title":"Deciphering mechanisms of brain metastasis in melanoma - the gist of the matter","volume":"17","author":"Redmer","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2026.119472_bib81","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.3390\/ijms17091468","article-title":"Melanoma Brain Metastasis: Mechanisms, Models, and Medicine","volume":"17","author":"Kircher","year":"2016","journal-title":"IJMS"},{"key":"10.1016\/j.biopha.2026.119472_bib82","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.bbrc.2016.07.009","article-title":"Extracellular S100A4 affects endothelial cell integrity and stimulates transmigration of A375 melanoma cells","volume":"477","author":"Herwig","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2026.119472_bib83","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/jcmm.12808","article-title":"Interaction of extracellular S100A4 with RAGE prompts prometastatic activation of A375 melanoma cells","volume":"20","author":"Herwig","year":"2016","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.biopha.2026.119472_bib84","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072480","article-title":"Therapeutic Targeting of Tumor Growth and Angiogenesis with a Novel Anti-S100A4 Monoclonal Antibody","volume":"8","author":"Hern\u00e1ndez","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.biopha.2026.119472_bib85","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1158\/1078-0432.CCR-14-0861","article-title":"PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis","volume":"21","author":"Jilaveanu","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2026.119472_bib86","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.3390\/cells12111513","article-title":"The Vicious Cycle of Melanoma-Microglia Crosstalk: Inter-Melanoma Variations in the Brain-Metastasis-Promoting IL-6\/JAK\/STAT3 Signaling Pathway","volume":"12","author":"Izraely","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2026.119472_bib87","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/neuonc\/noab159","article-title":"The PI3K\/Akt\/mTOR pathway as a preventive target in melanoma brain metastasis","volume":"24","author":"Tehranian","year":"2022","journal-title":"Neuro-Oncol."},{"key":"10.1016\/j.biopha.2026.119472_bib88","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1158\/2159-8290.CD-21-1006","article-title":"Melanoma-Secreted Amyloid Beta Suppresses Neuroinflammation and Promotes Brain Metastasis","volume":"12","author":"Kleffman","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.biopha.2026.119472_bib89","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/19336918.2015.1122156","article-title":"Transmigration characteristics of breast cancer and melanoma cells through the brain endothelium: Role of Rac and PI3K","volume":"10","author":"Moln\u00e1r","year":"2016","journal-title":"Cell Adhes. Migr."},{"key":"10.1016\/j.biopha.2026.119472_bib90","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10456-019-09693-x","article-title":"Vascular co-option in brain metastasis","volume":"23","author":"Garc\u00eda-G\u00f3mez","year":"2020","journal-title":"Angiogenesis"},{"key":"10.1016\/j.biopha.2026.119472_bib91","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1158\/1078-0432.CCR-22-1682","article-title":"Oral IRAK-4 Inhibitor CA-4948 Is Blood-Brain Barrier Penetrant and Has Single-Agent Activity against CNS Lymphoma and Melanoma Brain Metastases","volume":"29","author":"Von Roemeling","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2026.119472_bib92","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/neuonc\/noac212","article-title":"A distinct pattern of growth and RAC1 signaling in melanoma brain metastasis cells","volume":"25","author":"Stejerean-Todoran","year":"2023","journal-title":"Neuro-Oncol."},{"key":"10.1016\/j.biopha.2026.119472_bib93","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41571-019-0320-3","article-title":"Current approaches to the management of brain metastases","volume":"17","author":"Suh","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biopha.2026.119472_bib94","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13014-021-01754-0","article-title":"Single institutional outcomes of whole brain radiotherapy for metastatic melanoma brain metastases","volume":"16","author":"Jiang","year":"2021","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.biopha.2026.119472_bib95","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.clineuro.2009.11.004","article-title":"Short-course whole-brain radiotherapy (WBRT) for brain metastases due to small-cell lung cancer (SCLC)","volume":"112","author":"Bohlen","year":"2010","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.biopha.2026.119472_bib96","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70102","article-title":"The Optimal Radiotherapy Strategy for Patients With Small Cell Lung Cancer and Brain Metastasis: A Retrospective Analysis","volume":"30","author":"Zeng","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.biopha.2026.119472_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109744","article-title":"Stereotactic radiosurgery versus whole-brain radiotherapy in patients with 4\u201310 brain metastases: A nonrandomized controlled trial","volume":"186","author":"Bodensohn","year":"2023","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.biopha.2026.119472_bib98","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJM199002223220802","article-title":"A Randomized Trial of Surgery in the Treatment of Single Metastases to the Brain","volume":"322","author":"Patchell","year":"1990","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.biopha.2026.119472_bib99","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1001\/jama.295.21.2483","article-title":"Stereotactic Radiosurgery Plus Whole-Brain Radiation Therapy vs Stereotactic Radiosurgery Alone for Treatment of Brain Metastases: A Randomized Controlled Trial","volume":"295","author":"Aoyama","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.biopha.2026.119472_bib100","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1200\/JCO.2011.41.0639","volume":"31","author":"Soffietti","year":"2013","journal-title":"JCO"},{"key":"10.1016\/j.biopha.2026.119472_bib101","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.radonc.2022.06.022","article-title":"Efficacy and safety of recombinant human endostatin combined with whole-brain radiation therapy in patients with brain metastases from non-small cell lung cancer","volume":"174","author":"Chen","year":"2022","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.biopha.2026.119472_bib102","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.ijrobp.2020.02.639","article-title":"BRAINSTORM: A Multi-Institutional Phase 1\/2 Study of RRx-001 in Combination With Whole Brain Radiation Therapy for Patients With Brain Metastases","volume":"107","author":"Kim","year":"2020","journal-title":"Int. J. Radiat. Oncol. *Biol. *Phys."},{"key":"10.1016\/j.biopha.2026.119472_bib103","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1200\/JCO.2017.75.9589","article-title":"Whole-Brain Radiotherapy for Brain Metastases: Evolution or Revolution?","volume":"36","author":"Brown","year":"2018","journal-title":"JCO"},{"key":"10.1016\/j.biopha.2026.119472_bib104","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1200\/JCO.2014.57.2909","article-title":"Preservation of Memory With Conformal Avoidance of the Hippocampal Neural Stem-Cell Compartment During Whole-Brain Radiotherapy for Brain Metastases (RTOG 0933): A Phase II Multi-Institutional Trial","volume":"32","author":"Gondi","year":"2014","journal-title":"JCO"},{"key":"10.1016\/j.biopha.2026.119472_bib105","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.radonc.2022.02.011","article-title":"Improving on whole-brain radiotherapy in patients with large brain metastases: A planning study to support the AROMA clinical trial","volume":"170","author":"Chen","year":"2022","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.biopha.2026.119472_bib106","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1002\/cncr.32787","article-title":"Hippocampus-avoidance whole-brain radiation therapy with a simultaneous integrated boost for multiple brain metastases","volume":"126","author":"Popp","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.biopha.2026.119472_bib107","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/neuonc\/noad226","article-title":"Evaluating the heterogeneity of hippocampal avoidant whole brain radiotherapy treatment effect: A secondary analysis of NRG CC001","volume":"26","author":"Cherng","year":"2024","journal-title":"Neuro-Oncol."},{"key":"10.1016\/j.biopha.2026.119472_bib108","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/neuonc\/noaa193","article-title":"Hippocampal avoidance whole-brain radiotherapy without memantine in preserving neurocognitive function for brain metastases: a phase II blinded randomized trial","volume":"23","author":"Yang","year":"2021","journal-title":"Neuro-Oncol."},{"key":"10.1016\/j.biopha.2026.119472_bib109","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.prro.2011.12.004","article-title":"Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): An American Society for Radiation Oncology evidence-based guideline","volume":"2","author":"Tsao","year":"2012","journal-title":"Pract. Radiat. Oncol."},{"key":"10.1016\/j.biopha.2026.119472_bib110","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S1470-2045(17)30441-2","article-title":"Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C\/CEC\u00b73): a multicentre, randomised, controlled, phase 3 trial","volume":"18","author":"Brown","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.biopha.2026.119472_bib111","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1200\/JCO.2018.78.6186","article-title":"Effects of Surgery With Salvage Stereotactic Radiosurgery Versus Surgery With Whole-Brain Radiation Therapy in Patients With One to Four Brain Metastases (JCOG0504): A Phase III, Noninferiority, Randomized Controlled Trial","volume":"36","author":"Kayama","year":"2018","journal-title":"JCO"},{"key":"10.1016\/j.biopha.2026.119472_bib112","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/neuonc\/noae201","article-title":"Stereotactic radiosurgery for 1\u201310 brain metastases to avoid whole-brain radiotherapy: Results of the CYBER-SPACE randomized phase 2 trial","volume":"27","author":"El Shafie","year":"2025","journal-title":"Neuro-Oncol."},{"key":"10.1016\/j.biopha.2026.119472_bib113","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41571-025-01013-1","article-title":"Stereotactic radiosurgery for patients with brain metastases: current principles, expanding indications and opportunities for multidisciplinary care","volume":"22","author":"Mansouri","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biopha.2026.119472_bib114","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.ijrobp.2019.03.052","article-title":"Initial SRS for Patients With 5\u201315 Brain Metastases: Results of a Multi-Institutional Experience","volume":"104","author":"Hughes","year":"2019","journal-title":"Int. J. Radiat. Oncol. *Biol. *Phys."},{"key":"10.1016\/j.biopha.2026.119472_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110540","article-title":"Local control and toxicity after stereotactic radiotherapy in brain metastases patients and the impact of novel systemic treatments","volume":"200","author":"Van Schie","year":"2024","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.biopha.2026.119472_bib116","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.lungcan.2022.11.019","article-title":"Multicenter analysis of stereotactic radiosurgery for multiple brain metastases from EGFR and ALK driven non-small cell lung cancer","volume":"176","author":"Wandrey","year":"2023","journal-title":"Lung Cancer"},{"key":"10.1016\/j.biopha.2026.119472_bib117","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-006871","article-title":"Nivolumab and ipilimumab with concurrent stereotactic radiosurgery for intracranial metastases from non-small cell lung cancer: analysis of the safety cohort for non-randomized, open-label, phase I\/II trial","volume":"11","author":"Altan","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.biopha.2026.119472_bib118","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.radonc.2021.06.026","article-title":"Stereotactic radiosurgery for brain metastases from small cell lung cancer without prior whole-brain radiotherapy: A meta-analysis","volume":"162","author":"Viani","year":"2021","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.biopha.2026.119472_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2025.115567","article-title":"Combined immunotherapy with nivolumab and ipilimumab with and without sequential or concomitant stereotactic radiotherapy in patients with melanoma brain metastasis: An international retrospective study","volume":"225","author":"Mandal\u00e0","year":"2025","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.biopha.2026.119472_bib120","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-011432","article-title":"Nivolumab and stereotactic radiosurgery for patients with breast cancer brain metastases: long-term results and biomarker analysis from a non-randomized, open-label, phase Ib study","volume":"13","author":"Ahmed","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.biopha.2026.119472_bib121","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jamaoncol.2021.1262","article-title":"Efficacy and Safety of Stereotactic Radiosurgery for Brainstem Metastases: A Systematic Review and Meta-analysis","volume":"7","author":"Chen","year":"2021","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.biopha.2026.119472_bib122","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1001\/jamaoncol.2025.1770","article-title":"Therapy, Safety, and Logistics of Preoperative vs Postoperative Stereotactic Radiation Therapy: A Preliminary Analysis of a Randomized Clinical Trial","volume":"11","author":"Yeboa","year":"2025","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.biopha.2026.119472_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.103043","article-title":"Stereotactic reirradiation for local failure of brain metastases following previous radiosurgery: Systematic review and meta-analysis","volume":"153","author":"Loi","year":"2020","journal-title":"Crit. Rev. Oncol. \/Hematol."},{"key":"10.1016\/j.biopha.2026.119472_bib124","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1093\/neuonc\/noae076","article-title":"Phase I trial of dose escalation for preoperative stereotactic radiosurgery for patients with large brain metastases","volume":"26","author":"Murphy","year":"2024","journal-title":"Neuro-Oncol."},{"key":"10.1016\/j.biopha.2026.119472_bib125","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3171\/2019.5.JNS19222","article-title":"Outcome evaluation of patients treated with fractionated Gamma Knife radiosurgery for large (> 3 cm) brain metastases: a dose-escalation study","volume":"133","author":"Kim","year":"2020","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.biopha.2026.119472_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104540","article-title":"Role of osimertinib plus brain radiotherapy versus osimertinib single therapy in EGFR-mutated non-small-cell lung cancer with brain metastases: A meta-analysis and systematic review","volume":"205","author":"Nepote","year":"2025","journal-title":"Crit. Rev. Oncol. \/Hematol."},{"key":"10.1016\/j.biopha.2026.119472_bib127","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41392-024-01927-9","article-title":"Gefitinib (an EGFR tyrosine kinase inhibitor) plus anlotinib (an multikinase inhibitor) for untreated, EGFR-mutated, advanced non-small cell lung cancer (FL-ALTER): a multicenter phase III trial","volume":"9","author":"Zhou","year":"2024","journal-title":"Sig Transduct. Target Ther."},{"key":"10.1016\/j.biopha.2026.119472_bib128","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1200\/JCO.2015.65.5936","article-title":"Multicenter Phase II Study of Whole-Body and Intracranial Activity With Ceritinib in Patients With ALK -Rearranged Non\u2013Small-Cell Lung Cancer Previously Treated With Chemotherapy and Crizotinib: Results From ASCEND-2","volume":"34","author":"Crin\u00f2","year":"2016","journal-title":"JCO"},{"key":"10.1016\/j.biopha.2026.119472_bib129","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S1470-2045(14)70362-6","article-title":"Safety and activity of alectinib against systemic disease and brain metastases in patients with crizotinib-resistant ALK-rearranged non-small-cell lung cancer (AF-002JG): results from the dose-finding portion of a phase 1\/2 study","volume":"15","author":"Gadgeel","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.biopha.2026.119472_bib130","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(17)30565-2","article-title":"Alectinib versus crizotinib in patients with ALK -positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial","volume":"390","author":"Hida","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2026.119472_bib131","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1704795","article-title":"Alectinib versus Crizotinib in Untreated ALK -Positive Non\u2013Small-Cell Lung Cancer","volume":"377","author":"Peters","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2026.119472_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100342","article-title":"Safety and activity of alectinib plus bevacizumab in patients with advanced ALK-rearranged non-small-cell lung cancer: a phase I\/II study","volume":"7","author":"Lin","year":"2022","journal-title":"ESMO Open"},{"key":"10.1016\/j.biopha.2026.119472_bib133","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1200\/JCO.18.01511","article-title":"TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2\u2013Positive Breast Cancer and Brain Metastases","volume":"37","author":"Freedman","year":"2019","journal-title":"JCO"},{"key":"10.1016\/j.biopha.2026.119472_bib134","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1470-2045(12)70432-1","article-title":"Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study","volume":"14","author":"Bachelot","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.biopha.2026.119472_bib135","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.ijrobp.2023.07.019","article-title":"Concurrent Lapatinib With Brain Radiation Therapy in Patients With HER2+ Breast Cancer With Brain Metastases: NRG Oncology\u2013KROG\/RTOG 1119 Phase 2 Randomized Trial","volume":"118","author":"Kim","year":"2024","journal-title":"Int. J. Radiat. Oncol. *Biol. *Phys."},{"key":"10.1016\/j.biopha.2026.119472_bib136","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1038\/s41467-022-29081-2","article-title":"p16INK4A-deficiency predicts response to combined HER2 and CDK4\/6 inhibition in HER2+ breast cancer brain metastases","volume":"13","author":"Ni","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119472_bib137","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1200\/JCO.20.02822","article-title":"Pertuzumab Plus High-Dose Trastuzumab in Patients With Progressive Brain Metastases and HER2-Positive Metastatic Breast Cancer: Primary Analysis of a Phase II Study","volume":"39","author":"Lin","year":"2021","journal-title":"JCO"},{"key":"10.1016\/j.biopha.2026.119472_bib138","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.annonc.2020.06.020","article-title":"Trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer and brain metastases: exploratory final analysis of cohort 1 from KAMILLA, a single-arm phase IIIb clinical trial \u2729","volume":"31","author":"Montemurro","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.biopha.2026.119472_bib139","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.annonc.2020.05.014","article-title":"Phase I dose-escalation trial of tucatinib in combination with trastuzumab in patients with HER2-positive breast cancer brain metastases","volume":"31","author":"Metzger Filho","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.biopha.2026.119472_bib140","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/modpathol.2017.104","article-title":"Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine","volume":"31","author":"Cheng","year":"2018","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.biopha.2026.119472_bib141","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jmoldx.2012.10.002","article-title":"Frequency and Spectrum of BRAF Mutations in a Retrospective, Single-Institution Study of 1112 Cases of Melanoma","volume":"15","author":"Greaves","year":"2013","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.biopha.2026.119472_bib142","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/annonc\/mdw641","article-title":"Vemurafenib in metastatic melanoma patients with brain metastases: an open-label, single-arm, phase 2, multicentre study","volume":"28","author":"McArthur","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.biopha.2026.119472_bib143","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S1470-2045(12)70431-X","article-title":"Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial","volume":"13","author":"Long","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.biopha.2026.119472_bib144","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S1470-2045(17)30429-1","article-title":"Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial","volume":"18","author":"Davies","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.biopha.2026.119472_bib145","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/S1470-2045(16)30578-2","article-title":"Factors predictive of response, disease progression, and overall survival after dabrafenib and trametinib combination treatment: a pooled analysis of individual patient data from randomised trials","volume":"17","author":"Long","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.biopha.2026.119472_bib146","doi-asserted-by":"crossref","first-page":"991","DOI":"10.6004\/jnccn.2023.7032","article-title":"BRAF\/MEK Inhibition as a Bridge to Immunotherapy for Symptomatic BRAF V600 Melanoma Brain Metastases: A Case Series","volume":"21","author":"Strelnikov","year":"2023","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.biopha.2026.119472_bib147","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70102","article-title":"Addition of anti-PD-1 immunotherapy to BRAF inhibitor-based targeted therapy improves real-world survival and delays brain metastases in patients with BRAFV600 -mutant advanced melanoma: a multicenter cohort study","volume":"6","author":"Wu","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.biopha.2026.119472_bib148","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104462","article-title":"Treatment of melanoma brain metastases with radiation and immunotherapy or targeted therapy: A systematic review with meta-analysis","volume":"202","author":"Williams","year":"2024","journal-title":"Crit. Rev. Oncol. \/Hematol."},{"key":"10.1016\/j.biopha.2026.119472_bib149","article-title":"First line immunotherapy extends brain metastasis free survival, improves overall survival, and reduces the incidence of brain metastasis in patients with advanced melanoma","volume":"4","author":"Wang","year":"2021","journal-title":"Cancer Rep."},{"key":"10.1016\/j.biopha.2026.119472_bib150","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/cam4.3716","article-title":"Real world outcomes of combination and timing of immunotherapy with radiotherapy for melanoma with brain metastases","volume":"10","author":"Moyers","year":"2021","journal-title":"Cancer Med."},{"key":"10.1016\/j.biopha.2026.119472_bib151","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.592796","article-title":"Stereotactic Radiosurgery With Concurrent Immunotherapy in Melanoma Brain Metastases Is Feasible and Effective","volume":"10","author":"Liermann","year":"2020","journal-title":"Front Oncol."},{"key":"10.1016\/j.biopha.2026.119472_bib152","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/1754-9485.13403","article-title":"Stereotactic radiosurgery for melanoma brain metastases: Concurrent immune checkpoint inhibitor therapy associated with superior clinicoradiological response outcomes","volume":"66","author":"Shanker","year":"2022","journal-title":"J. Med Imag. Rad. Onc"},{"key":"10.1016\/j.biopha.2026.119472_bib153","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1634\/theoncologist.2018-0306","article-title":"Upfront Surgical Resection of Melanoma Brain Metastases Provides a Bridge Toward Immunotherapy-Mediated Systemic Control","volume":"24","author":"Alvarez-Breckenridge","year":"2019","journal-title":"Oncologist"},{"key":"10.1016\/j.biopha.2026.119472_bib154","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000333","article-title":"Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG* study in 380 patients","volume":"8","author":"Amaral","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.biopha.2026.119472_bib155","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/S1470-2045(21)00545-3","article-title":"Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label, multicentre, phase 2 study","volume":"22","author":"Tawbi","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.biopha.2026.119472_bib156","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-97566-z","article-title":"Impact of KRAS mutation status on the efficacy of immunotherapy in lung cancer brain metastases","volume":"11","author":"Lauko","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119472_bib157","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.cllc.2020.10.014","article-title":"Combined Immunotherapy and Stereotactic Radiotherapy Improves Neurologic Outcomes in Patients with Non\u2013small-cell Lung Cancer Brain Metastases","volume":"22","author":"Enright","year":"2021","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.biopha.2026.119472_bib158","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.3390\/cancers12123668","article-title":"Gamma Knife Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer Patients Treated with Immunotherapy or Targeted Therapy","volume":"12","author":"Cho","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2026.119472_bib159","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1093\/neuonc\/noab129","article-title":"Immunotherapy in association with stereotactic radiotherapy for non-small cell lung cancer brain metastases: results from a multicentric retrospective study on behalf of AIRO","volume":"23","author":"Scoccianti","year":"2021","journal-title":"Neuro-Oncol."},{"key":"10.1016\/j.biopha.2026.119472_bib160","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.9553","article-title":"Effectiveness of Immune Checkpoint Inhibition vs Chemotherapy in Combination With Radiation Therapy Among Patients With Non\u2013Small Cell Lung Cancer and Brain Metastasis Undergoing Neurosurgical Resection","volume":"5","author":"Wasilewski","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.biopha.2026.119472_bib161","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11060-022-03951-7","article-title":"Local control outcomes for combination of stereotactic radiosurgery and immunotherapy for non-small cell lung cancer brain metastases","volume":"157","author":"Abdulhaleem","year":"2022","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.biopha.2026.119472_bib162","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S1470-2045(22)00224-8","article-title":"Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"23","author":"Wang","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.biopha.2026.119472_bib163","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-01455-4","article-title":"Local, multimodal intralesional therapy renders distant brain metastases susceptible to PD-L1 blockade in a preclinical model of triple-negative breast cancer","volume":"11","author":"Yokoi","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119472_bib164","article-title":"Case Report: Long-Term Response to Pembrolizumab Combined With Endocrine Therapy in Metastatic Breast Cancer Patients With Hormone Receptor Expression","volume":"12","author":"Wu","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2026.119472_bib165","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3171\/2008.8.JNS08448","article-title":"Reduced local recurrence of a single brain metastasis through microscopic total resection: Clinical article","volume":"110","author":"Yoo","year":"2009","journal-title":"JNS"},{"key":"10.1016\/j.biopha.2026.119472_bib166","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1007\/s00701-012-1463-5","article-title":"Proof of principle: supramarginal resection of cerebral metastases in eloquent brain areas","volume":"154","author":"Kamp","year":"2012","journal-title":"Acta Neurochir."},{"key":"10.1016\/j.biopha.2026.119472_bib167","doi-asserted-by":"crossref","first-page":"698","DOI":"10.3171\/2016.2.JNS152855","article-title":"Functional approach using intraoperative brain mapping and neurophysiological monitoring for the surgical treatment of brain metastases in the central region","volume":"126","author":"Sanmillan","year":"2017","journal-title":"JNS"},{"key":"10.1016\/j.biopha.2026.119472_bib168","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1200\/JCO.2005.04.6235","article-title":"Resectable Brain Metastases","volume":"24","author":"Vogelbaum","year":"2006","journal-title":"JCO"},{"key":"10.1016\/j.biopha.2026.119472_bib169","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s13311-017-0520-4","article-title":"Convection-Enhanced Delivery","volume":"14","author":"Mehta","year":"2017","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.biopha.2026.119472_bib170","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1807105115","article-title":"Mechanisms of enhanced drug delivery in brain metastases with focused ultrasound-induced blood\u2013tumor barrier disruption","volume":"115","author":"Arvanitis","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2026.119472_bib171","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.3171\/2013.1.JNS1291","article-title":"Results of the NeuroBlate System first-in-humans Phase I clinical trial for recurrent glioblastoma: Clinical article","volume":"118","author":"Sloan","year":"2013","journal-title":"JNS"},{"key":"10.1016\/j.biopha.2026.119472_bib172","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.2147\/IJN.S23588","article-title":"Advances in cancer therapy through the use of carbon nanotube-mediated targeted hyperthermia","author":"Iancu","year":"2011","journal-title":"IJN"},{"key":"10.1016\/j.biopha.2026.119472_bib173","doi-asserted-by":"crossref","first-page":"804","DOI":"10.3171\/2017.11.JNS171273","article-title":"Laser ablation after stereotactic radiosurgery: a multicenter prospective study in patients with metastatic brain tumors and radiation necrosis","volume":"130","author":"Ahluwalia","year":"2019","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.biopha.2026.119472_bib174","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1227\/NEU.0000000000000144","article-title":"Magnetic Resonance Imaging-Guided Focused Laser Interstitial Thermal Therapy for Intracranial Lesions","volume":"73","author":"Hawasli","year":"2013","journal-title":"Neurosurgery"},{"key":"10.1016\/j.biopha.2026.119472_bib175","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41563-019-0566-2","article-title":"The entry of nanoparticles into solid tumours","volume":"19","author":"Sindhwani","year":"2020","journal-title":"Nat. Mater."},{"key":"10.1016\/j.biopha.2026.119472_bib176","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1002\/jps.23994","article-title":"Enhanced Doxorubicin Delivery to the Brain Administered Through Glutathione PEGylated Liposomal Doxorubicin (2B3-101) as Compared with Generic Caelyx,\u00ae\/Doxil\u00ae\u2014A Cerebral Open Flow Microperfusion Pilot Study","volume":"103","author":"Birngruber","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2026.119472_bib177","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1007\/s13346-021-01039-9","article-title":"Harnessing nanomedicine for enhanced immunotherapy for breast cancer brain metastases","volume":"11","author":"Carney","year":"2021","journal-title":"Drug Deliv. Transl. Res"},{"key":"10.1016\/j.biopha.2026.119472_bib178","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jconrel.2018.12.040","article-title":"Macrophage entrapped silica coated superparamagnetic iron oxide particles for controlled drug release in a 3D cancer model","volume":"294","author":"Ullah","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2026.119472_bib179","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.3390\/ijms20061280","article-title":"Innovative Therapeutic Strategies for Effective Treatment of Brain Metastases","volume":"20","author":"Lim","year":"2019","journal-title":"IJMS"},{"key":"10.1016\/j.biopha.2026.119472_bib180","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1471-4159.2011.07208.x","article-title":"Quantitative targeted absolute proteomics of human blood\u2013brain barrier transporters and receptors","volume":"117","author":"Uchida","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2026.119472_bib181","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3109\/10611861003587235","article-title":"In vitro and in vivo investigation of glucose-mediated brain-targeting liposomes","volume":"18","author":"Qin","year":"2010","journal-title":"J. Drug Target."},{"key":"10.1016\/j.biopha.2026.119472_bib182","article-title":"Development of Polymeric Nanoparticles for Blood\u2013Brain Barrier Transfer\u2014Strategies and Challenges","volume":"8","author":"Zhang","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biopha.2026.119472_bib183","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1208\/s12248-008-9055-2","article-title":"CNS Delivery Via Adsorptive Transcytosis","volume":"10","author":"Herv\u00e9","year":"2008","journal-title":"AAPS J."},{"key":"10.1016\/j.biopha.2026.119472_bib184","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jconrel.2023.12.001","article-title":"Nanomaterials for brain metastasis","volume":"365","author":"Zhao","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2026.119472_bib185","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1158\/1078-0432.CCR-16-3193","article-title":"64Cu-MM-302 Positron Emission Tomography Quantifies Variability of Enhanced Permeability and Retention of Nanoparticles in Relation to Treatment Response in Patients with Metastatic Breast Cancer","volume":"23","author":"Lee","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2026.119472_bib186","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1158\/1535-7163.MCT-15-0314","article-title":"Cyclophosphamide-Mediated Tumor Priming for Enhanced Delivery and Antitumor Activity of HER2-Targeted Liposomal Doxorubicin (MM-302)","volume":"14","author":"Geretti","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.biopha.2026.119472_bib187","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1038\/s41598-022-06677-8","article-title":"Dual targeting micelles loaded with paclitaxel and lapatinib for combinational therapy of brain metastases from breast cancer","volume":"12","author":"Lu","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119472_bib188","article-title":"Biomimetic Nanoerythrosome-Coated Aptamer\u2013DNA Tetrahedron\/Maytansine Conjugates: pH-Responsive and Targeted Cytotoxicity for HER2-Positive Breast Cancer","volume":"34","author":"Ma","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biopha.2026.119472_bib189","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1021\/acs.molpharmaceut.1c00224","article-title":"Prodrug Delivery Using Dual-Targeting Nanoparticles To Treat Breast Cancer Brain Metastases","volume":"18","author":"Ju","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biopha.2026.119472_bib190","article-title":"Systemic Delivery of Monoclonal Antibodies to the Central Nervous System for Brain Tumor Therapy","volume":"31","author":"Han","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biopha.2026.119472_bib191","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jconrel.2015.03.023","article-title":"Targeting of metastasis-promoting tumor-associated fibroblasts and modulation of pancreatic tumor-associated stroma with a carboxymethylcellulose-docetaxel nanoparticle","volume":"206","author":"Ernsting","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2026.119472_bib192","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41568-021-00427-0","article-title":"Towards targeting of shared mechanisms of cancer metastasis and therapy resistance","volume":"22","author":"Weiss","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2026.119472_bib193","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201900543","article-title":"Multitargeted Nanoparticles Deliver Synergistic Drugs across the Blood\u2013Brain Barrier to Brain Metastases of Triple Negative Breast Cancer Cells and Tumor-Associated Macrophages","volume":"8","author":"Zhang","year":"2019","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.biopha.2026.119472_bib194","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jconrel.2022.07.009","article-title":"Microenvironment-tailored micelles restrain carcinoma-astrocyte crosstalk for brain metastasis","volume":"349","author":"Zhao","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2026.119472_bib195","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1038\/s41467-018-04529-6","article-title":"Blood\u2013brain barrier opening in Alzheimer\u2019s disease using MR-guided focused ultrasound","volume":"9","author":"Lipsman","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119472_bib196","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.jconrel.2013.09.014","article-title":"Coupling of drug containing liposomes to microbubbles improves ultrasound triggered drug delivery in mice","volume":"172","author":"Cool","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2026.119472_bib197","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abf7390","article-title":"Single-cell analysis reveals effective siRNA delivery in brain tumors with microbubble-enhanced ultrasound and cationic nanoparticles","volume":"7","author":"Guo","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biopha.2026.119472_bib198","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191102","article-title":"Ultrasound-mediated delivery and distribution of polymeric nanoparticles in the normal brain parenchyma of a metastatic brain tumour model","volume":"13","author":"Baghirov","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.biopha.2026.119472_bib199","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201700474","article-title":"Focused Ultrasound-Augmented Delivery of Biodegradable Multifunctional Nanoplatforms for Imaging-Guided Brain Tumor Treatment","volume":"5","author":"Wu","year":"2018","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biopha.2026.119472_bib200","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216870","article-title":"Circulating tumor cells with metastasis-initiating competence survive fluid shear stress during hematogenous dissemination through CXCR4-PI3K\/AKT signaling","volume":"590","author":"Xin","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2026.119472_bib201","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.246","article-title":"Circulating tumor cell characterization of lung cancer brain metastases in the cerebrospinal fluid through single-cell transcriptome analysis","volume":"10","author":"Ruan","year":"2020","journal-title":"Clin. & Transl. Med"},{"key":"10.1016\/j.biopha.2026.119472_bib202","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41416-022-01768-9","article-title":"Circulating tumour cells in the -omics era: how far are we from achieving the \u2018singularity\u2019?","volume":"127","author":"Visal","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2026.119472_bib203","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.cell.2020.10.026","article-title":"High-Spatial-Resolution Multi-Omics Sequencing via Deterministic Barcoding in Tissue","volume":"183","author":"Liu","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2026.119472_bib204","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/s41593-021-00842-4","article-title":"Integrating barcoded neuroanatomy with spatial transcriptional profiling enables identification of gene correlates of projections","volume":"24","author":"Sun","year":"2021","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.biopha.2026.119472_bib205","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/neuonc\/noae219","article-title":"The immune landscape in brain metastasis","volume":"27","author":"Schreurs","year":"2025","journal-title":"Neuro-Oncol."},{"key":"10.1016\/j.biopha.2026.119472_bib206","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/s42003-023-05124-2","article-title":"Single-cell sequencing reveals the landscape of the human brain metastatic microenvironment","volume":"6","author":"Song","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.biopha.2026.119472_bib207","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114613","article-title":"Lipid-associated macrophages for osimertinib resistance and leptomeningeal metastases in NSCLC","volume":"43","author":"Li","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2026.119472_bib208","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41586-022-05680-3","article-title":"Single-cell spatial immune landscapes of primary and metastatic brain tumours","volume":"614","author":"Karimi","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119472_bib209","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41392-025-02241-8","article-title":"Neuro-immune crosstalk in cancer: mechanisms and therapeutic implications","volume":"10","author":"Pu","year":"2025","journal-title":"Sig Transduct. Target Ther."},{"key":"10.1016\/j.biopha.2026.119472_bib210","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.tem.2024.04.009","article-title":"Lipid-associated macrophages between aggravation and alleviation of metabolic diseases","volume":"35","author":"Xu","year":"2024","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2026.119472_bib211","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ade3559","article-title":"TREM2 inhibition triggers antitumor cell activity of myeloid cells in glioblastoma","volume":"9","author":"Sun","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biopha.2026.119472_bib212","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1158\/2767-9764.CRC-22-0336","article-title":"Targeting Lymphoma-associated Macrophage Expansion via CSF1R\/JAK Inhibition is a Therapeutic Vulnerability in Peripheral T-cell Lymphomas","volume":"2","author":"Gao","year":"2022","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.biopha.2026.119472_bib213","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41573-022-00390-x","article-title":"Function and therapeutic value of astrocytes in neurological diseases","volume":"21","author":"Lee","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2026.119472_bib214","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112646","article-title":"A novel PROTAC molecule dBET1 alleviates pathogenesis of experimental autoimmune encephalomyelitis in mice by degrading BRD4","volume":"139","author":"Song","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2026.119472_bib215","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3390\/tomography9030090","article-title":"Advances in Focused Ultrasound for the Treatment of Brain Tumors","volume":"9","author":"Rao","year":"2023","journal-title":"Tomography"},{"key":"10.1016\/j.biopha.2026.119472_bib216","doi-asserted-by":"crossref","first-page":"9180","DOI":"10.1073\/pnas.2002571117","article-title":"Noninvasive hippocampal blood\u2212brain barrier opening in Alzheimer\u2019s disease with focused ultrasound","volume":"117","author":"Rezai","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2026.119472_bib217","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.ibneur.2025.04.007","article-title":"The emerging role of circulating tumor DNA in brain tumor research","volume":"18","author":"Chahardehi","year":"2025","journal-title":"IBRO Neurosci. Rep."},{"key":"10.1016\/j.biopha.2026.119472_bib218","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41591-024-03286-y","article-title":"Prediction of brain metastasis development with DNA methylation signatures","volume":"31","author":"Zuccato","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2026.119472_bib219","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1186\/s12967-023-04681-8","article-title":"A multi-task deep learning model for EGFR genotyping prediction and GTV segmentation of brain metastasis","volume":"21","author":"Zhou","year":"2023","journal-title":"J. Transl. Med."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226005081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226005081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T09:55:25Z","timestamp":1794477325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226005081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":219,"alternative-id":["S0753332226005081"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119472","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in mechanisms and treatments of brain metastases","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119472","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119472"}}